Quality of life(QOL) has accompanied the treatment of AIDS patients, along with pharmacologicalinnovations that have allowed patients to live longer and maintain their well-being.The present study aimed at evaluating the QOL of these patients and correlateit with clinical and laboratory data. The study included 205 patients with HIV/AIDS,who answered the WHOQOL-120-HIV; and whose socio-demographic data, clinicaland laboratory findings were collected. The average age was 40.59 ± 11.81years; CD4+ lymphocyte count, 397.9 ± 232.84 mm3; and yearsof diagnosis of HIV, 5.23 ± 3.94. Viral load was <50 copies/ml in 115patients; 50 to 10.000 in 61; and above 10.000 copies in 29 patients. Domainsachieved satisfactory average scores, and the best were the psychological (14.5± 2.7), followed by social relationships (13.7 ± 2.2), physical (12.7± 3.5), independence (12.6 ± 2.5), personal beliefs (12.4 ± 2.4),and environment (12.4 ± 1.8). The best scores on pain, pleasure, socialsupport, physical environment, and personal belief facets were observed forthose with higher CD4 levels (p < 0.05). The best scores for the finance,leisure, concerns about the future, overall QOL, and perceived health facetswere observed for patients with viral load <50 (p < 0.05). The highestrates for energy, fatigue, sexual activity, information, transportation, symptoms,care, and concerns about the future facets were seen in patients with less timeof diagnosis (p < 0.05). HIV/AIDS patients in the study had an intermediateQOL correlating to CD4 levels, VL, and time of diagnosis.
